Trial Profile
A Phase I Single Arm Trial Combining Radiotherapy and Temozolomide With Dichloracetate (DCA) [sodium dichloroacetate] in Patients With Newly Diagnosed Glioblastoma Multiform Tumours.
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase I
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Sodium dichloroacetate (Primary) ; Temozolomide
- Indications Glioblastoma
- Focus Adverse reactions
- 21 Sep 2011 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 21 Jul 2008 New trial record.